Albert Mwango

2.2k citations

28 papers · 1.9k · 1 hit paper · h-index 17

Impact in

Infectious Diseases top 1%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Tuberculosis Research and Epidemiology
Emergency Medicine top 5%
- HIV-related health complications and treatments

Papers in

Infectious Diseases 26
- HIV/AIDS Research and Interventions 24
- HIV/AIDS drug development and treatment 4
Toxicology 1
- Pharmacovigilance and Adverse Drug Reactions 1

Co-authors: Jeffrey S. A. Stringer (14 shared papers)Ronald A. Cantrell (5 shared papers)Jens Levy (4 shared papers)Marc Bulterys (4 shared papers)Stewart E. Reid (6 shared papers)Elizabeth M. Stringer (4 shared papers)Moses Sinkala (2 shared papers)Michael S. Saag (4 shared papers)
Journals: PLoS ONE (6 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (5 papers)JAMA (2 papers)International Journal of Epidemiology (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: Zambia United States United Kingdom

In The Last Decade

Albert Mwango

28 papers receiving 1.8k citations

Albert Mwango's Hit Papers

align trajectories log scale

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. 2006 · 577 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2006 PubMed

Peers

Countries citing papers authored by Albert Mwango

Since Specialization

Citations

This map shows the geographic impact of Albert Mwango's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Mwango with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Mwango more than expected).

Fields of papers citing papers by Albert Mwango

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Mwango. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Mwango. The network helps show where Albert Mwango may publish in the future.

Co-authors

The 25 scholars most cited alongside Albert Mwango, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Albert Mwango Line = papers co-authored together Albert Mwango links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. PubMed ·Jeffrey S. A. Stringer, Isaac Zulu, Jens Levy, Elizabeth M. Stringer, Albert Mwango, Vilepe Mtonga, Stewart E. Reid, Ronald A. Cantrell Hit paper breakdown →	2006	577
2	Clinical Outcomes and CD4 Cell Response in Children Receiving Antiretroviral Therapy at Primary Health Care Facilities in Zambia JAMA ·Carolyn Bolton‐Moore, Mwangelwa Mubiana‐Mbewe, Ronald A. Cantrell, Namwinga Chintu, Elizabeth M. Stringer, Moses Sinkala, Chipepo Kankasa, Craig M. Wilson	2007	305
3	Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America PLoS Medicine ·Constantin Theodore Yiannoutsos, Andrew O. Westfall, Jamie E. Newman, Jialun Zhou, Carina César, Martin W. G. Brinkhof, Albert Mwango, Éric Balestre	2011	184
4	Use of task-shifting to rapidly scale-up HIV treatment services: experiences from Lusaka, Zambia BMC Health Services Research ·Mary Morris, Bushimbwa Tambatamba Chapula, Albert Mwango, Joyce Mwanza, Handson Manda, Carolyn Bolton‐Moore, Debra S Pankratz, Jeffrey S. A. Stringer	2009	139
5	Adherence Support Workers: A Way to Address Human Resource Constraints in Antiretroviral Treatment Programs in the Public Health Setting in Zambia PLoS ONE ·Kwasi Torpey, Mushota Kabaso, Liya N. Mutale, Mpuma Kamanga, Albert Mwango, James Simpungwe, Ya Diul Mukadi +1 other	2008	91
6	Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia International Journal of Epidemiology ·B. H. Chi, Ronald A. Cantrell, Idah Zulu, Lloyd Mulenga, Jens Levy, Bushimbwa C. Tambatamba, Stewart E. Reid, Albert Mwango	2009	84
7	Effect of Baseline Renal Function on Tenofovir-Containing Antiretroviral Therapy Outcomes in Zambia Clinical Infectious Diseases ·Lloyd Mulenga, Patrick Musonda, Albert Mwango, Michael J. Vinikoor, Mary‐Ann Davies, Aggrey Mweemba, Alexandra Calmy, Jeffrey S. A. Stringer	2014	57
8	An Empirical Approach to Defining Loss to Follow-up Among Patients Enrolled in Antiretroviral Treatment Programs American Journal of Epidemiology ·B. H. Chi, Ronald A. Cantrell, Albert Mwango, Andrew O. Westfall, Wilbroad Mutale, Mohammed Limbada, Lloyd Mulenga, Sten H. Vermund	2010	56
9	Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland PLoS ONE ·Franziska Schöni-Affolter, Olivia Keiser, Albert Mwango, Jeffrey S. A. Stringer, Bruno Ledergerber, Lloyd Mulenga, Heiner C. Bucher, Andrew O. Westfall	2011	56
10	Early Clinical and Programmatic Outcomes with Tenofovir-Based Antiretroviral Therapy in Zambia JAIDS Journal of Acquired Immune Deficiency Syndromes ·Albert Mwango, Mark J Giganti, Lloyd Mulenga, Bushimbwa Tambatamba Chapula, Stewart E. Reid, Carolyn Bolton‐Moore, Namwinga Chintu, Priscilla Lumano Mulenga	2010	55
11	Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia PLoS ONE ·Elliot A. Marseille, Mark J Giganti, Albert Mwango, Angela Chisembele‐Taylor, Lloyd Mulenga, Mead Over, James G. Kahn, Jeffrey S. A. Stringer	2012	42
12	Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial The Lancet Global Health ·Ranjeeta Thomas, Ronelle Burger, Abigail Joan Harper, Sarah Kanema, Lawrence Mwenge, Nosivuyile Vanqa, Nomtha Bell‐Mandla, PETER C. SMITH	2017	39
13	Health Outcomes and Cost Impact of the New WHO 2013 Guidelines on Prevention of Mother-to-Child Transmission of HIV in Zambia PLoS ONE ·Naoko Ishikawa, Takuro Shimbo, Shinsuke Miyano, Izukanji T Sikazwe, Albert Mwango, Massimo Ghidinelli, Gardner Syakantu	2014	33
14	Quality improvement intervention to increase adherence to ART prescription policy at HIV treatment clinics in Lusaka, Zambia: A cluster randomized trial PLoS ONE ·Elizabeth A. McCarthy, Hamsa L. Subramaniam, Margaret Lippitt Prust, Marta Rose Prescott, Felton Mpasela, Albert Mwango, Leah Namonje, Crispin Moyo	2017	28
15	Nutrition and inflammation serum biomarkers are associated with 12‐week mortality among malnourished adults initiating antiretroviral therapy in Zambia Journal of the International AIDS Society ·John Robert Koethe, Meridith L Blevins, Christopher K. Nyirenda, Edmond Kato Kabagambe, Bryan E. Shepherd, C. William Wester, Isaac Zulu, Janelle Marie Chiasera	2011	27
16	Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa Public Health Nutrition ·John Robert Koethe, Meridith L Blevins, Claire N. Bosire, Christopher K. Nyirenda, Edmond Kato Kabagambe, Albert Mwango, Webster Kasongo, Isaac Zulu	2012	18
17	A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia PLoS ONE ·Paul C. Wang, Albert Mwango, Sarah A. Moberley, Benjamin J. Brockman, Alison L. Connor, Kalesha-Masumbu Penelope, Simon Mutembo, Maximillian Bweupe	2015	17
18	Comparative Outcomes of Tenofovir-Based and Zidovudine-Based Antiretroviral Therapy Regimens in Lusaka, Zambia JAIDS Journal of Acquired Immune Deficiency Syndromes ·Albert Mwango, Mark J Giganti, Izukanji T Sikazwe, Crispin Moyo, Linnaea Schuttner, Lloyd Mulenga, Carolyn Bolton‐Moore, Namwinga Chintu	2011	16
19	Pharmacovigilance and new essential drugs in Africa: Zambia draws lessons from its own experiences and beyond Global Public Health ·Maggie Huff‐Rousselle, Oscar Ozmund Simooya, V. Kabwe, Ray Handema, Albert Mwango, Ernest Mwape +1 other	2007	13
20	Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study International Journal of Epidemiology ·Jeffrey S. A. Stringer, Albert Mwango, M. J. Giganti, Lloyd Mulenga, Jens Levy, E. M. Stringer, P. Mulenga, Michael S. Saag	2012	11

About Albert Mwango

Albert Mwango is a scholar working on Infectious Diseases, Toxicology, Emergency Medical Services, General Health Professions and Economics and Econometrics, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (24 papers), HIV/AIDS drug development and treatment (4 papers), Nursing Roles and Practices (1 paper), Global Health Workforce Issues (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper) and HIV/AIDS Impact and Responses (1 paper). The work is most often cited by research in Infectious Diseases (1.6k citations), Emergency Medicine (102 citations), Emergency Medical Services (73 citations), Virology (49 citations) and General Health Professions (103 citations). Albert Mwango has collaborated with scholars based in Zambia, United States and United Kingdom. Frequent co-authors include Jeffrey S. A. Stringer, Ronald A. Cantrell, Jens Levy, Marc Bulterys, Stewart E. Reid, Elizabeth M. Stringer, Moses Sinkala, Michael S. Saag, Alwyn Mwinga and Isaac Zulu. Their work appears in journals such as PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes, JAMA, International Journal of Epidemiology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Albert Mwango

Impact in

Papers in i

In The Last Decade

Albert Mwango

Albert Mwango's Hit Papers

Peers

Countries citing papers authored by Albert Mwango

Fields of papers citing papers by Albert Mwango

All Works

About Albert Mwango

Explore authors with similar magnitude of impact

Papers in